In experimental T cell transfer colitis, IL-23 amplifies GM-CSF production by Th17 cells, enhancing extramedullary hematopoiesis, accumulating progenitor granulocyte-monocyte cells in the colon, and activating eosinophils that contribute to tissue damage in colitis [68,69]. This evidence concerns the gene CSF2 and colitis.